gliclazide has been researched along with Pemphigoid, Bullous in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Pemphigoid, Bullous: A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vildagliptin is a new drug used to treat diabetes mellitus (DM)." | 5.46 | A case of bullous pemphigoid ınduced by vildagliptin. ( Ersoy-Evans, S; Gököz, O; Gönül, M; Keseroglu, HO; Taş-Aygar, G, 2017) |
| "Vildagliptin is a new drug used to treat diabetes mellitus (DM)." | 1.46 | A case of bullous pemphigoid ınduced by vildagliptin. ( Ersoy-Evans, S; Gököz, O; Gönül, M; Keseroglu, HO; Taş-Aygar, G, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keseroglu, HO | 1 |
| Taş-Aygar, G | 1 |
| Gönül, M | 1 |
| Gököz, O | 1 |
| Ersoy-Evans, S | 1 |
1 other study available for gliclazide and Pemphigoid, Bullous
| Article | Year |
|---|---|
A case of bullous pemphigoid ınduced by vildagliptin.
Topics: Adamantane; Administration, Cutaneous; Clobetasol; Complement C3; Diabetes Mellitus, Type 2; Dipepti | 2017 |